The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer
- PMID: 28521512
- PMCID: PMC5705788
- DOI: 10.2217/epi-2017-0034
The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer
Abstract
Mammalian SWI/SNF enzymes are ATP-dependent remodelers of chromatin structure. These multisubunit enzymes are heterogeneous in composition; there are two catalytic ATPase subunits, BRM and BRG1, that are mutually exclusive, and additional subunits are incorporated in a combinatorial manner. Recent findings indicate that approximately 20% of human cancers contain mutations in SWI/SNF enzyme subunits, leading to the conclusion that the enzyme subunits are critical tumor suppressors. However, overexpression of specific subunits without apparent mutation is emerging as an alternative mechanism by which cellular transformation may occur. Here we highlight recent evidence linking elevated expression of the BRG1 ATPase to tissue-specific cancers and work suggesting that inhibiting BRG1 may be an effective therapeutic strategy.
Keywords: ADAADi; BRG1; BRM; PFI-3; breast cancer; cancer metabolism; chromatin remodeling; drug transporters; mammalian SWI/SNF enzymes.
Conflict of interest statement
The authors and this work were supported by National Institutes of Health grants P01 CA82834 and R21 CA185926. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Figures
Similar articles
-
Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.Epigenetics Chromatin. 2017 Dec 22;10(1):62. doi: 10.1186/s13072-017-0167-8. Epigenetics Chromatin. 2017. PMID: 29273066 Free PMC article.
-
Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia.Mol Cancer Res. 2022 Mar 1;20(3):361-372. doi: 10.1158/1541-7786.MCR-21-0390. Mol Cancer Res. 2022. PMID: 34799403
-
Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.Epigenetics. 2008 Mar-Apr;3(2):64-8. doi: 10.4161/epi.3.2.6153. Epub 2008 Apr 17. Epigenetics. 2008. PMID: 18437052 Review.
-
Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.Mol Cell Biol. 2014 Mar;34(6):1136-44. doi: 10.1128/MCB.01372-13. Epub 2014 Jan 13. Mol Cell Biol. 2014. PMID: 24421395 Free PMC article.
-
The SWI/SNF complex and cancer.Oncogene. 2009 Apr 9;28(14):1653-68. doi: 10.1038/onc.2009.4. Epub 2009 Feb 23. Oncogene. 2009. PMID: 19234488 Review.
Cited by
-
Transcriptional Activation of Matricellular Protein Spondin2 (SPON2) by BRG1 in Vascular Endothelial Cells Promotes Macrophage Chemotaxis.Front Cell Dev Biol. 2020 Aug 14;8:794. doi: 10.3389/fcell.2020.00794. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32974343 Free PMC article.
-
Nuclear Receptor Coregulators in Hormone-Dependent Cancers.Cancers (Basel). 2022 May 13;14(10):2402. doi: 10.3390/cancers14102402. Cancers (Basel). 2022. PMID: 35626007 Free PMC article. Review.
-
BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma.Nat Commun. 2021 Nov 26;12(1):6924. doi: 10.1038/s41467-021-27176-w. Nat Commun. 2021. PMID: 34836971 Free PMC article.
-
Structure of the BRK domain of the SWI/SNF chromatin remodeling complex subunit BRG1 reveals a potential role in protein-protein interactions.Protein Sci. 2020 Apr;29(4):1047-1053. doi: 10.1002/pro.3820. Epub 2020 Jan 13. Protein Sci. 2020. PMID: 31909846 Free PMC article.
-
What is new in epithelioid soft tissue tumors?Virchows Arch. 2020 Jan;476(1):81-96. doi: 10.1007/s00428-019-02677-8. Epub 2019 Nov 4. Virchows Arch. 2020. PMID: 31686193 Review.
References
-
- Imbalzano AN, Kwon H, Green MR, Kingston RE. Facilitated binding of TATA-binding protein to nucleosomal DNA. Nature. 1994;370(6489):481–485. - PubMed
-
- Kwon H, Imbalzano AN, Khavari PA, Kingston RE, Green MR. Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complex. Nature. 1994;370(6489):477–481. - PubMed
-
- Quinn J, Fyrberg AM, Ganster RW, Schmidt MC, Peterson CL. DNA-binding properties of the yeast SWI/SNF complex. Nature. 1996;379(6568):844–847. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous